{ "resourceType" : "Bundle", "id" : "5bb930aa-f30d-4f10-aeef-e85f6b5f8d59", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-bundle"] }, "type" : "collection", "entry" : [{ "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/MedicinalProductDefinition/Estalis-Transdermalpatch", "resource" : { "resourceType" : "MedicinalProductDefinition", "id" : "Estalis-Transdermalpatch", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition"] }, "text" : { "status" : "extensions", "div" : "

Generated Narrative: MedicinalProductDefinition Estalis-Transdermalpatch

Profile: MedicinalProductDefinition

CH SMC - Authorized Dose Form: Transdermal patch

identifier: Medical Product Identifier/CH-01006431-0547040020000

indication:

Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.

\n

legalStatusOfSupply: Medicinal product subject to medical or veterinary prescription (B)

additionalMonitoringIndicator: No Warning

pediatricUseIndicator: Not authorised for the treatment in children

classification: norethisterone and estrogen, NA KAS art. 12 para. 5 TPLO, Synthetic, Originator product, 07. STOFFWECHSEL, 07.08. Geschlechtshormone, 07.08.60. Kombinationen

attachedDocument:

name

productName: ESTALIS Matrixpfl 50/250 24 Stk

type: FOPH Medicinal Product Name

Usages

-CountryLanguage
*SwitzerlandGerman (Switzerland)
" }, "extension" : [{ "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/authorizedDoseForm", "valueCodeableConcept" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "10519000", "display" : "Transdermal patch" }] } }], "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/mpid", "value" : "CH-01006431-0547040020000" }], "indication" : "Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.", "legalStatusOfSupply" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply", "code" : "756005022003", "display" : "Medicinal product subject to medical or veterinary prescription (B)" }] }, "additionalMonitoringIndicator" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator", "code" : "756005001003", "display" : "No Warning" }] }, "pediatricUseIndicator" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator", "code" : "756005003002", "display" : "Not authorised for the treatment in children" }] }, "classification" : [{ "coding" : [{ "system" : "http://www.whocc.no/atc", "code" : "G03FA01" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category", "code" : "756005021001", "display" : "NA KAS art. 12 para. 5 TPLO" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode", "code" : "756005004001", "display" : "Synthetic" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type", "code" : "756001003002", "display" : "Originator product" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus", "code" : "070000", "display" : "07. STOFFWECHSEL" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus", "code" : "070800", "display" : "07.08. Geschlechtshormone" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus", "code" : "070860", "display" : "07.08.60. Kombinationen" }] }], "attachedDocument" : [{ "reference" : "DocumentReference/DocRef-FI-Estalis" }, { "reference" : "DocumentReference/DocRef-PI-Estalis" }], "name" : [{ "productName" : "ESTALIS Matrixpfl 50/250 24 Stk", "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type", "code" : "FOPH", "display" : "FOPH Medicinal Product Name" }] }, "usage" : [{ "country" : { "coding" : [{ "system" : "urn:iso:std:iso:3166", "code" : "CH", "display" : "Switzerland" }] }, "language" : { "coding" : [{ "system" : "urn:ietf:bcp:47", "code" : "de-CH", "display" : "German (Switzerland)" }] } }] }] } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/DocumentReference/DocRef-FI-Estalis", "resource" : { "resourceType" : "DocumentReference", "id" : "DocRef-FI-Estalis", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-documentreference"] }, "language" : "de-CH", "text" : { "status" : "generated", "div" : "

Generated Narrative: DocumentReference DocRef-FI-Estalis

Language: de-CH

Profile: DocumentReference

identifier: Application / Assessment Tracking Number/123456789-initial submission-Example-hij-123

status: Current

type: Fachinformation

date: 2021-10-01 00:00:00+0000

content

Attachments

-Url
*https://swissmedicinfo.ch/showTextAccepted.aspx?textType=FI&lang=DE&authNr=54704&supportMultipleResults=1
" }, "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/attno", "value" : "123456789-initial submission-Example-hij-123" }], "status" : "current", "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type", "code" : "756005007001", "display" : "Fachinformation" }] }, "date" : "2021-10-01T00:00:00Z", "content" : [{ "attachment" : { "url" : "https://swissmedicinfo.ch/showTextAccepted.aspx?textType=FI&lang=DE&authNr=54704&supportMultipleResults=1" } }] } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/DocumentReference/DocRef-PI-Estalis", "resource" : { "resourceType" : "DocumentReference", "id" : "DocRef-PI-Estalis", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-documentreference"] }, "language" : "de-CH", "text" : { "status" : "generated", "div" : "

Generated Narrative: DocumentReference DocRef-PI-Estalis

Language: de-CH

Profile: DocumentReference

identifier: Application / Assessment Tracking Number/123456789-initial submission-Example-hij-321

status: Current

type: Patienteninformation

date: 2021-10-01 00:00:00+0000

content

Attachments

-Url
*https://swissmedicinfo.ch/showTextAccepted.aspx?textType=PI&lang=DE&authNr=54704&supportMultipleResults=1
" }, "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/attno", "value" : "123456789-initial submission-Example-hij-321" }], "status" : "current", "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type", "code" : "756005007002", "display" : "Patienteninformation" }] }, "date" : "2021-10-01T00:00:00Z", "content" : [{ "attachment" : { "url" : "https://swissmedicinfo.ch/showTextAccepted.aspx?textType=PI&lang=DE&authNr=54704&supportMultipleResults=1" } }] } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/RegulatedAuthorization/MA-5470402", "resource" : { "resourceType" : "RegulatedAuthorization", "id" : "MA-5470402", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: RegulatedAuthorization MA-5470402

Profile: RegulatedAuthorization

identifier: Marketing Authorisation Number/5470402

subject: MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01006431-0547040020000; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.08. Geschlechtshormone,07.08.60. Kombinationen

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 1999-08-17

holder: Organization Sandoz Pharmaceuticals AG

regulator: Organization Swissmedic Swiss Agency for Therapeutic Products


Generated Narrative: Organization #holder-Sandoz-Pharmaceuticals-AG

Profile: Organization

identifier: Swissmedic Location Identifier/01006431, LOC Identifier/100054743, GLN Identifier/7601001029439

name: Sandoz Pharmaceuticals AG


Generated Narrative: Organization #regulator-SMC

Profile: Organization

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: Swissmedic Swiss Agency for Therapeutic Products

" }, "contained" : [{ "resourceType" : "Organization", "id" : "holder-Sandoz-Pharmaceuticals-AG", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://www.swissmedic.ch/fhir/identifier/locations", "value" : "01006431" }, { "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100054743" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001029439" }], "name" : "Sandoz Pharmaceuticals AG" }, { "resourceType" : "Organization", "id" : "regulator-SMC", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100010911" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001398511" }], "name" : "Swissmedic Swiss Agency for Therapeutic Products" }], "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/authno", "value" : "5470402" }], "subject" : [{ "reference" : "MedicinalProductDefinition/Estalis-Transdermalpatch" }], "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type", "code" : "756000002001", "display" : "Marketing Authorisation" }] }, "region" : [{ "coding" : [{ "system" : "urn:iso:std:iso:3166", "code" : "CH", "display" : "Switzerland" }] }], "status" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status", "code" : "756005023007", "display" : "valid" }] }, "statusDate" : "1999-08-17", "holder" : { "reference" : "#holder-Sandoz-Pharmaceuticals-AG" }, "regulator" : { "reference" : "#regulator-SMC" } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/PackagedProductDefinition/PMP-Estalis-Transdermalpatch", "resource" : { "resourceType" : "PackagedProductDefinition", "id" : "PMP-Estalis-Transdermalpatch", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-packagedproductdefinition"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: PackagedProductDefinition PMP-Estalis-Transdermalpatch

Profile: PackagedProductDefinition

identifier: Clinical Product Identifier/CH-01006431-0547040020000-0097

packageFor: MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01006431-0547040020000; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.08. Geschlechtshormone,07.08.60. Kombinationen

containedItemQuantity: 24 Patch (Details: EDQM - Standard Terms code15036000 = 'Patch')

description:

ESTALIS Matrixpfl 50/250 24 Stk

\n

LegalStatusOfSupplies

-Code
*Medicinal product subject to medical or veterinary prescription (B)

packaging

identifier: Global Trade Item Number/7680547040979

type: Box

quantity: 1

ShelfLifeStorages

-TypePeriod[x]SpecialPrecautionsForStorage
*Shelf life of the medicinal product as packaged for saleNo display for Duration (value: 6; unit: month; system: http://unitsofmeasure.org; code: mo)protect from light
" }, "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/pcid", "value" : "CH-01006431-0547040020000-0097" }], "packageFor" : [{ "reference" : "MedicinalProductDefinition/Estalis-Transdermalpatch" }], "containedItemQuantity" : [{ "value" : 24, "unit" : "Patch", "system" : "http://standardterms.edqm.eu", "code" : "15036000" }], "description" : "ESTALIS Matrixpfl 50/250 24 Stk", "legalStatusOfSupply" : [{ "code" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply", "code" : "756005022003", "display" : "Medicinal product subject to medical or veterinary prescription (B)" }] } }], "packaging" : { "identifier" : [{ "system" : "urn:oid:2.51.1.1", "value" : "7680547040979" }], "type" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "30009000", "display" : "Box" }] }, "quantity" : 1, "shelfLifeStorage" : [{ "type" : { "coding" : [{ "system" : "http://spor.ema.europa.eu/v1/lists/100000073343", "code" : "100000073403", "display" : "Shelf life of the medicinal product as packaged for sale" }] }, "periodDuration" : { "value" : 6, "unit" : "month", "system" : "http://unitsofmeasure.org", "code" : "mo" }, "specialPrecautionsForStorage" : [{ "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-special-precautions-for-storage", "code" : "756005042004", "display" : "protect from light" }] }] }] } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/RegulatedAuthorization/MA-54704089", "resource" : { "resourceType" : "RegulatedAuthorization", "id" : "MA-54704089", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: RegulatedAuthorization MA-54704089

Profile: RegulatedAuthorization

identifier: Marketing Authorisation Number/54704089

subject: MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01006431-0547040020000; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.08. Geschlechtshormone,07.08.60. Kombinationen

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 1999-08-17

holder: Organization Sandoz Pharmaceuticals AG

regulator: Organization Swissmedic Swiss Agency for Therapeutic Products


Generated Narrative: Organization #holder-Sandoz-Pharmaceuticals-AG

Profile: Organization

identifier: Swissmedic Location Identifier/01006431, LOC Identifier/100054743, GLN Identifier/7601001029439

name: Sandoz Pharmaceuticals AG


Generated Narrative: Organization #regulator-SMC

Profile: Organization

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: Swissmedic Swiss Agency for Therapeutic Products

" }, "contained" : [{ "resourceType" : "Organization", "id" : "holder-Sandoz-Pharmaceuticals-AG", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://www.swissmedic.ch/fhir/identifier/locations", "value" : "01006431" }, { "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100054743" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001029439" }], "name" : "Sandoz Pharmaceuticals AG" }, { "resourceType" : "Organization", "id" : "regulator-SMC", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100010911" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001398511" }], "name" : "Swissmedic Swiss Agency for Therapeutic Products" }], "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/authno", "value" : "54704089" }], "subject" : [{ "reference" : "MedicinalProductDefinition/Estalis-Transdermalpatch" }], "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type", "code" : "756000002001", "display" : "Marketing Authorisation" }] }, "region" : [{ "coding" : [{ "system" : "urn:iso:std:iso:3166", "code" : "CH", "display" : "Switzerland" }] }], "status" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status", "code" : "756005023007", "display" : "valid" }] }, "statusDate" : "1999-08-17", "holder" : { "reference" : "#holder-Sandoz-Pharmaceuticals-AG" }, "regulator" : { "reference" : "#regulator-SMC" } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/RegulatedAuthorization/FOPH-17418", "resource" : { "resourceType" : "RegulatedAuthorization", "id" : "FOPH-17418", "text" : { "status" : "extensions", "div" : "

Generated Narrative: RegulatedAuthorization FOPH-17418

CH EPL - Reimbursement SL

url

FOPHDossierNumber

value: FOPH Dossier Number/17418

url

status

value: Reimbursed

url

statusDate

value: 2000-04-15

url

listingStatus

value: Listed

url

listingPeriod

value: 2000-04-15 --> (ongoing)

url

firstListingDate

value: 2000-04-15

url

costShare

value: 10

url

gamme

value: Transdermal

value: CHF32.44 (CHF)

type: Ex-factory price

changeType: Price mutation after triennal review of pharmaceuticals

changeDate: 2014-11-01

url

CH EPL - Product Price

value: CHF53.65 (CHF)

type: Retail price

changeType: VAT-change

changeDate: 2024-01-01

url

CH EPL - Product Price

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-01006431-0547040020000-0097; containedItemQuantity = 24 Patch; description = ESTALIS Matrixpfl 50/250 24 Stk

type: Reimbursement SL

Indications

-ExtensionReference
*ClinicalUseDefinition: type = indication

holder: Organization Sandoz Pharmaceuticals AG


Generated Narrative: Organization #holder-Sandoz-Pharmaceuticals-AG

Profile: Organization

identifier: Swissmedic Location Identifier/01006431, LOC Identifier/100054743, GLN Identifier/7601001029439

name: Sandoz Pharmaceuticals AG

" }, "contained" : [{ "resourceType" : "Organization", "id" : "holder-Sandoz-Pharmaceuticals-AG", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://www.swissmedic.ch/fhir/identifier/locations", "value" : "01006431" }, { "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100054743" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001029439" }], "name" : "Sandoz Pharmaceuticals AG" }], "extension" : [{ "extension" : [{ "url" : "FOPHDossierNumber", "valueIdentifier" : { "system" : "urn:oid:2.16.756.1", "value" : "17418" } }, { "url" : "status", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-reimbursement-status", "code" : "756001021001", "display" : "Reimbursed" }] } }, { "url" : "statusDate", "valueDate" : "2000-04-15" }, { "url" : "listingStatus", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-listing-status", "code" : "756001002001", "display" : "Listed" }] } }, { "url" : "listingPeriod", "valuePeriod" : { "start" : "2000-04-15" } }, { "url" : "firstListingDate", "valueDate" : "2000-04-15" }, { "url" : "costShare", "valueInteger" : 10 }, { "url" : "gamme", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-gamme", "code" : "756002004012", "display" : "Transdermal" }] } }, { "extension" : [{ "url" : "value", "valueMoney" : { "value" : 32.44, "currency" : "CHF" } }, { "url" : "type", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type", "code" : "756002005002", "display" : "Ex-factory price" }] } }, { "url" : "changeType", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change", "code" : "756002006010", "display" : "Price mutation after triennal review of pharmaceuticals" }] } }, { "url" : "changeDate", "valueDate" : "2014-11-01" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice" }, { "extension" : [{ "url" : "value", "valueMoney" : { "value" : 53.65, "currency" : "CHF" } }, { "url" : "type", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type", "code" : "756002005001", "display" : "Retail price" }] } }, { "url" : "changeType", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change", "code" : "756002006008", "display" : "VAT-change" }] } }, { "url" : "changeDate", "valueDate" : "2024-01-01" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/reimbursementSL" }], "subject" : [{ "reference" : "PackagedProductDefinition/PMP-Estalis-Transdermalpatch" }], "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type", "code" : "756000002003", "display" : "Reimbursement SL" }] }, "indication" : [{ "extension" : [{ "extension" : [{ "url" : "status", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-limitationstatus", "code" : "756002071001", "display" : "Limitation Reimbursed" }] } }, { "url" : "statusDate", "valueDate" : "2000-04-15" }, { "url" : "period", "valuePeriod" : { "start" : "2000-04-15" } }, { "url" : "firstLimitationDate", "valueDate" : "2000-04-15" }, { "extension" : [{ "url" : "value", "valueMoney" : { "value" : 32.44, "currency" : "CHF" } }, { "url" : "type", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type", "code" : "756002005002", "display" : "Ex-factory price" }] } }, { "url" : "changeType", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change", "code" : "756002006010", "display" : "Price mutation after triennal review of pharmaceuticals" }] } }, { "url" : "changeDate", "valueDate" : "2014-11-01" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice" }, { "extension" : [{ "url" : "value", "valueMoney" : { "value" : 53.65, "currency" : "CHF" } }, { "url" : "type", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type", "code" : "756002005001", "display" : "Retail price" }] } }, { "url" : "changeType", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change", "code" : "756002006008", "display" : "VAT-change" }] } }, { "url" : "changeDate", "valueDate" : "2024-01-01" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/regulatedAuthorization-limitation" }], "reference" : { "reference" : "ClinicalUseDefinition/IND-10031285" } }], "holder" : { "reference" : "#holder-Sandoz-Pharmaceuticals-AG" } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/ManufacturedItemDefinition/MI-Estradiolum-Norethisteroni-Transdermalpatch", "resource" : { "resourceType" : "ManufacturedItemDefinition", "id" : "MI-Estradiolum-Norethisteroni-Transdermalpatch", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-manufactureditemdefinition"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: ManufacturedItemDefinition MI-Estradiolum-Norethisteroni-Transdermalpatch

Profile: ManufacturedItemDefinition

status: Active

manufacturedDoseForm: Transdermal patch

unitOfPresentation: Patch

" }, "status" : "active", "manufacturedDoseForm" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "10519000", "display" : "Transdermal patch" }] }, "unitOfPresentation" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "15036000", "display" : "Patch" }] } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/AdministrableProductDefinition/PhP-Estradiolum-Norethisteroni-Transdermalpatch", "resource" : { "resourceType" : "AdministrableProductDefinition", "id" : "PhP-Estradiolum-Norethisteroni-Transdermalpatch", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: AdministrableProductDefinition PhP-Estradiolum-Norethisteroni-Transdermalpatch

Profile: AdministrableProductDefinition

status: Active

formOf: MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01006431-0547040020000; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.08. Geschlechtshormone,07.08.60. Kombinationen

administrableDoseForm: Transdermal patch

unitOfPresentation: Patch

RouteOfAdministrations

-Code
*Transdermal use
" }, "status" : "active", "formOf" : [{ "reference" : "MedicinalProductDefinition/Estalis-Transdermalpatch" }], "administrableDoseForm" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "10519000", "display" : "Transdermal patch" }] }, "unitOfPresentation" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "15036000", "display" : "Patch" }] }, "routeOfAdministration" : [{ "code" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "20070000", "display" : "Transdermal use" }] } }] } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/ClinicalUseDefinition/IND-10030247", "resource" : { "resourceType" : "ClinicalUseDefinition", "id" : "IND-10030247", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-clinicalusedefinition-indication"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: ClinicalUseDefinition IND-10030247

Profile: ClinicalUseDefinition Indication

type: Indication

subject: MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01006431-0547040020000; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.08. Geschlechtshormone,07.08.60. Kombinationen

indication

DiseaseSymptomProcedures

-Concept
*Oestrogenmangel

Comorbidities

-Concept
*Menopause

IntendedEffects

-Concept
*preventive
" }, "type" : "indication", "subject" : [{ "reference" : "MedicinalProductDefinition/Estalis-Transdermalpatch" }], "indication" : { "diseaseSymptomProcedure" : { "concept" : { "coding" : [{ "system" : "https://www.meddra.org", "code" : "10030247", "display" : "Oestrogenmangel" }] } }, "comorbidity" : [{ "concept" : { "coding" : [{ "system" : "https://www.meddra.org", "code" : "10027308", "display" : "Menopause" }] } }], "intendedEffect" : { "concept" : { "coding" : [{ "system" : "http://spor.ema.europa.eu/v1/lists/200000003186", "code" : "200000003192", "display" : "preventive" }] } } } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/ClinicalUseDefinition/IND-10031285", "resource" : { "resourceType" : "ClinicalUseDefinition", "id" : "IND-10031285", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-clinicalusedefinition-indication"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: ClinicalUseDefinition IND-10031285

Profile: ClinicalUseDefinition Indication

type: Indication

subject: MedicinalProductDefinition: extension = Transdermal patch; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01006431-0547040020000; indication = Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Not authorised for the treatment in children; classification = norethisterone and estrogen,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.08. Geschlechtshormone,07.08.60. Kombinationen

indication

DiseaseSymptomProcedures

-Concept
*Osteoporose postmenopausal

IntendedEffects

-Concept
*preventive
" }, "type" : "indication", "subject" : [{ "reference" : "MedicinalProductDefinition/Estalis-Transdermalpatch" }], "indication" : { "diseaseSymptomProcedure" : { "concept" : { "coding" : [{ "system" : "https://www.meddra.org", "code" : "10031285", "display" : "Osteoporose postmenopausal" }] } }, "intendedEffect" : { "concept" : { "coding" : [{ "system" : "http://spor.ema.europa.eu/v1/lists/200000003186", "code" : "200000003192", "display" : "preventive" }] } } } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/Ingredient/Estradiol-hemihydrate-0.512mg", "resource" : { "resourceType" : "Ingredient", "id" : "Estradiol-hemihydrate-0.512mg", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-ingredient"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: Ingredient Estradiol-hemihydrate-0.512mg

Profile: Ingredient

status: Active

for:

role: Active

substance

Codes

-Concept
*Estradiol-hemihydrate

Strengths

-Presentation[x]
*0.512 mg (Details: UCUM codemg = 'mg')/1 Patch (Details: EDQM - Standard Terms code15036000 = 'Patch')
" }, "status" : "active", "for" : [{ "reference" : "AdministrableProductDefinition/PhP-Estradiolum-Norethisteroni-Transdermalpatch" }, { "reference" : "ManufacturedItemDefinition/MI-Estradiolum-Norethisteroni-Transdermalpatch" }], "role" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role", "code" : "756005051001", "display" : "Active" }] }, "substance" : { "code" : { "concept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance", "code" : "CXY7B3Q98Z", "display" : "Estradiol-hemihydrate" }] } }, "strength" : [{ "presentationRatio" : { "numerator" : { "value" : 0.512, "unit" : "mg", "system" : "http://unitsofmeasure.org", "code" : "mg" }, "denominator" : { "value" : 1, "unit" : "Patch", "system" : "http://standardterms.edqm.eu", "code" : "15036000" } } }] } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/Ingredient/Norethisteroni-acetas-0.496mg", "resource" : { "resourceType" : "Ingredient", "id" : "Norethisteroni-acetas-0.496mg", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-ingredient"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: Ingredient Norethisteroni-acetas-0.496mg

Profile: Ingredient

status: Active

for:

role: Active

substance

Codes

-Concept
*Norethisterone acetate

Strengths

-Presentation[x]
*0.496 mg (Details: UCUM codemg = 'mg')/1 Patch (Details: EDQM - Standard Terms code15036000 = 'Patch')
" }, "status" : "active", "for" : [{ "reference" : "AdministrableProductDefinition/PhP-Estradiolum-Norethisteroni-Transdermalpatch" }, { "reference" : "ManufacturedItemDefinition/MI-Estradiolum-Norethisteroni-Transdermalpatch" }], "role" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role", "code" : "756005051001", "display" : "Active" }] }, "substance" : { "code" : { "concept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance", "code" : "9S44LIC7OJ", "display" : "Norethisterone acetate" }] } }, "strength" : [{ "presentationRatio" : { "numerator" : { "value" : 0.496, "unit" : "mg", "system" : "http://unitsofmeasure.org", "code" : "mg" }, "denominator" : { "value" : 1, "unit" : "Patch", "system" : "http://standardterms.edqm.eu", "code" : "15036000" } } }] } } }] }